Search research articles
Contact Us
Filters
Showing results (261-270 of 279) with videos related to
Page
of 28
Sort By:
American Journal of Obstetrics and Gynecology
|
July 5, 2022
Medical management of early pregnancy loss is cost-effective compared with office uterine aspiration
Divyah Nagendra, Sarah M Gutman, Nathanael C Koelper, et al.
Harefuah
|
October 1, 1996
[Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]
S Abu-Abid, M Gutman, D Lev, et al.
Cancer
|
September 1, 1996
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer
M Gutman, S Abu-Abid, P Sorkine, et al.
Cancer Research
|
March 15, 1988
Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues
M Tal, M Wetzler, Z Josefberg, et al.
Oncology
|
January 11, 2001
Is forequarter amputation justified for palliation of intractable cancer symptoms?
O Merimsky, Y Kollender, M Inbar, et al.
Surgery
|
November 24, 1999
Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan
D Lev-Chelouche, S Abu-Abeid, R Nakache, et al.
The EMBO Journal
|
January 7, 1999
Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors
A C Papageorgiou, C M Collins, D M Gutman, et al.
Cancer Immunology, Immunotherapy : CII
|
October 1, 1994
Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells
S Huang, R K Singh, K Xie, et al.
Mutation Research
|
May 1, 1992
DNA sequences amplified in cancer cells: an interface between tumor biology and human genome analysis
Y Shiloh, O Mor, A Manor, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
October 1, 1995
Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustment
P Sorkin, S Abu-Abid, D Lev, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 279) with videos related to
Sort By:
Page
of 28
American Journal of Obstetrics and Gynecology
|
July 5, 2022
Medical management of early pregnancy loss is cost-effective compared with office uterine aspiration
Divyah Nagendra, Sarah M Gutman, Nathanael C Koelper, et al.
Harefuah
|
October 1, 1996
[Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs]
S Abu-Abid, M Gutman, D Lev, et al.
Cancer
|
September 1, 1996
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer
M Gutman, S Abu-Abid, P Sorkine, et al.
Cancer Research
|
March 15, 1988
Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues
M Tal, M Wetzler, Z Josefberg, et al.
Oncology
|
January 11, 2001
Is forequarter amputation justified for palliation of intractable cancer symptoms?
O Merimsky, Y Kollender, M Inbar, et al.
Surgery
|
November 24, 1999
Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan
D Lev-Chelouche, S Abu-Abeid, R Nakache, et al.
The EMBO Journal
|
January 7, 1999
Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors
A C Papageorgiou, C M Collins, D M Gutman, et al.
Cancer Immunology, Immunotherapy : CII
|
October 1, 1994
Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells
S Huang, R K Singh, K Xie, et al.
Mutation Research
|
May 1, 1992
DNA sequences amplified in cancer cells: an interface between tumor biology and human genome analysis
Y Shiloh, O Mor, A Manor, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
October 1, 1995
Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustment
P Sorkin, S Abu-Abid, D Lev, et al.
Page
of 28